(XRAY) DENTSPLY International Analysts Initiate Coverage as Neutral

We recently initiated coverage on DENTSPLY International Inc. (XRAY) with a Neutral recommendation. We rate the stock Neutral with a target price of $37 based on a P/E of 18.3x our 2010 EPS estimate of $2.02.

DENTSPLY reported third quarter fiscal 2009 earnings per share of 44 cents, in line with the Zacks Consensus Estimate but slightly lower than the year-ago figure of 46 cents. The company’s sales were roughly flat year over year at $531.0 million. Excluding the precious metal content, net sales increased 1.1% year over year.

Excluding the precious metal content, gross margin in the third quarter declined 210 basis points (bps) year over year to 55.3%. However, the company’s cost-control initiatives helped it increase the operating margin 220 bps year over year to 18.8%.

DENTSPLY expects earnings per share for full fiscal 2009 between $1.81 and $1.86. We might reconsider our Neutral recommendation based on the company’s performance in the next quarter.

The company has an aggressive acquisition strategy. DENTSPLY acquired several businesses in the past few years. Some prominent acquisitions include Dental Depot Lomberg B.V., E.S. Holding N.V., Sultan Healthcare, Inc., NEKS Technologies, Inc., assets of Apollonia & Fama Implant S.r.l, etc.

DENTSPLY is a global leader in the design, development, manufacture and marketing of dental consumables, dental laboratory products and dental specialty products. The company’s products are available in over 120 countries under some of the most well established brand names in the industry. DENTSPLY’s diversified product portfolio hedges it from any significant sales shortfall in economic downturns.

Zacks Investment Research

Related Posts:

  1. (FDO) Family Dollar Analyst Initiates Coverage at NeutralWe have recently initiated coverage on Family Dollar Stores Inc. (FDO), a self-service retail discount...
  2. (LEAP) Leap Wireless Analysts Initiate Coverage at NeutralWe initiate our coverage on Leap Wireless (LEAP) with a Neutral recommendation. The company is...
  3. (ERTS) Electronic Arts Analysts Initiate at NeutralWe are initiating Electronic Arts Inc. (ERTS) with a Neutral rating and an $18.00 price...
  4. (XRAY) Dentsply International Reports In-LineDentsply International Inc. (XRAY) reported third quarter earnings per share of 44 cents, in-line with...
  5. (GSK) Inhibitex Coverage Initiated at NeutralWe are initiating coverage of Inhibitex (INHX) with a ‘Neutral’ rating and $2 price target....
  6. (EMC) Initiating Coverage on EMC with Neutral StanceWe are initiating coverage of EMC Corporation (EMC) with a Neutral rating and a $16...


Search Posts by Tag: | | Healthcare

RSS Feeds by Tag: DENTSPLY International Inc | XRAY | Healthcare |

Other Posts by: | RSS Feed for this author